Raised concentrations of 5-LOX-derived leukotrienes, such as LTB4 and LTE4, have also been evidenced in the bronchoalveolar lavage fluid of intubated COVID-19 patients [56]. This evidence concerns the gene ALOX5 and COVID-19.